Brain atrophy assessment in multiple sclerosis: importance and limitations.

[1]  Stephen M. Smith,et al.  Enhanced brain extraction improves the accuracy of brain atrophy estimation , 2008, NeuroImage.

[2]  M. Absinta,et al.  Evidence of thalamic gray matter loss in pediatric multiple sclerosis , 2008, Neurology.

[3]  Karl J. Friston,et al.  Voxel-based morphometry , 2007 .

[4]  Stephen M. Smith,et al.  Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis , 2007, NeuroImage.

[5]  Chiara Romualdi,et al.  Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. , 2007, Archives of neurology.

[6]  Marco Rovaris,et al.  Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually‐edited SIENA and SIENAX , 2007, Journal of magnetic resonance imaging : JMRI.

[7]  C R G Guttmann,et al.  Thalamic atrophy and cognition in multiple sclerosis , 2007, Neurology.

[8]  M. Filippi,et al.  The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study , 2007, Multiple sclerosis.

[9]  Nick C. Fox,et al.  Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: Cross-validation of BSI, SIENA and SIENAX , 2007, NeuroImage.

[10]  Rohit Bakshi,et al.  Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis , 2007, NeuroImage.

[11]  R. Zivadinov.  Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis? , 2007, Neurology.

[12]  L. Kappos,et al.  MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS , 2007, Neurology.

[13]  Marco Battaglini,et al.  Measuring Brain Atrophy in Multiple Sclerosis , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[14]  Chiara Romualdi,et al.  Cortical atrophy is relevant in multiple sclerosis at clinical onset , 2007, Journal of Neurology.

[15]  A. Kangarlu,et al.  Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla. , 2007, AJNR. American journal of neuroradiology.

[16]  Chris Frost,et al.  Cerebral Atrophy Measurement in Clinically Isolated Syndromes and Relapsing Remitting Multiple Sclerosis: A Comparison of Registration‐Based Methods , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[17]  Alan C. Evans,et al.  Focal cortical atrophy in multiple sclerosis: Relation to lesion load and disability , 2007, NeuroImage.

[18]  Mark Jenkinson,et al.  Manifestations of early brain recovery associated with abstinence from alcoholism. , 2006, Brain : a journal of neurology.

[19]  Martola Juha,et al.  Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[20]  Alan J. Thompson,et al.  Localization of grey matter atrophy in early RRMS , 2006, Journal of Neurology.

[21]  J H Simon,et al.  Brain atrophy in multiple sclerosis: what we know and would like to know , 2006, Multiple sclerosis.

[22]  M Rovaris,et al.  Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. , 2006, Brain : a journal of neurology.

[23]  P. Matthews,et al.  Neocortical neuronal, synaptic, and glial loss in multiple sclerosis , 2006, Neurology.

[24]  Mara Cercignani,et al.  Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. , 2006, Archives of neurology.

[25]  R. Benedict,et al.  Predicting neuropsychological abnormalities in multiple sclerosis , 2006, Journal of the Neurological Sciences.

[26]  Nick C Fox,et al.  Magnetic resonance imaging measures of brain atrophy in multiple sclerosis , 2006, Journal of magnetic resonance imaging : JMRI.

[27]  G. Plant,et al.  Ventricular enlargement in MS , 2006, Neurology.

[28]  Rohit Bakshi,et al.  Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis , 2006, Neurology.

[29]  Bruno Alfano,et al.  Grey matter loss in relapsing–remitting multiple sclerosis: A voxel-based morphometry study , 2006, NeuroImage.

[30]  Rohit Bakshi,et al.  The measurement and clinical relevance of brain atrophy in multiple sclerosis , 2006, The Lancet Neurology.

[31]  Robert Zivadinov,et al.  Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS , 2006, NeuroImage.

[32]  W. Brück.  Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis , 2005, Journal of Neurology.

[33]  D. Arnold.  Changes observed in multiple sclerosis using magnetic resonance imaging reflect a focal pathology distributed along axonal pathways , 2005, Journal of Neurology.

[34]  M Rovaris,et al.  Evidence for progressive gray matter loss in patients with relapsing-remitting MS , 2005, Neurology.

[35]  G Tedeschi,et al.  Brain atrophy and lesion load in a large population of patients with multiple sclerosis , 2005, Neurology.

[36]  Rohit Bakshi,et al.  The relationship between whole brain volume and disability in multiple sclerosis: A comparison of normalized gray vs. white matter with misclassification correction , 2005, NeuroImage.

[37]  Frederik Barkhof,et al.  Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. , 2005, Radiology.

[38]  Mara Cercignani,et al.  Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. , 2005, Brain : a journal of neurology.

[39]  P. Matthews,et al.  Risk factors for progression of brain atrophy in aging , 2005, Neurology.

[40]  A J Thompson,et al.  Gray and white matter volume changes in early RRMS , 2005, Neurology.

[41]  M. Rovaris,et al.  Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. , 2005, AJNR. American journal of neuroradiology.

[42]  E. Radue,et al.  Rate of brain atrophy in relapsing MS decreases during treatment with IFNβ-1a , 2005, Neurology.

[43]  Mark W. Woolrich,et al.  Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.

[44]  D. Louis Collins,et al.  Relating neocortical pathology to disability progression in multiple sclerosis using MRI , 2004, NeuroImage.

[45]  Marco Rovaris,et al.  Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial , 2004, The Lancet.

[46]  Robert Zivadinov,et al.  Frontal parenchymal atrophy measures in multiple sclerosis , 2004, Multiple sclerosis.

[47]  C. Lucchinetti,et al.  Evidence for pathogenic heterogeneity in multiple sclerosis , 2004, Annals of neurology.

[48]  Natasa Kovacevic,et al.  Semiautomatic brain region extraction: a method of parcellating brain regions from structural magnetic resonance images , 2004, NeuroImage.

[49]  N. De Stefano,et al.  Neocortical volume decrease in relapsing–remitting MS patients with mild cognitive impairment , 2004, Neurology.

[50]  David H. Miller,et al.  Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.

[51]  S. Sorbi,et al.  Influence of Apolipoprotein E ϵ4 Genotype on Brain Tissue Integrity in Relapsing-Remitting Multiple Sclerosis , 2004 .

[52]  P. Matthews,et al.  Accelerated evolution of brain atrophy and “black holes” in MS patients with APOE‐ε4 , 2004, Annals of neurology.

[53]  P. Calabresi,et al.  Interferon-&bgr;-1b slows progression of atrophy in RRMS: Three-year follow-up in NAb− and NAb+ patients , 2004, Neurology.

[54]  A J Thompson,et al.  Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis , 2003, Multiple sclerosis.

[55]  A. Dale,et al.  Focal thinning of the cerebral cortex in multiple sclerosis. , 2003, Brain : a journal of neurology.

[56]  P. Jezzard,et al.  Thalamic neurodegeneration in relapsing-remitting multiple sclerosis , 2003, Neurology.

[57]  P. M. Matthews,et al.  Evidence of early cortical atrophy in MS , 2003, Neurology.

[58]  Rohit Bakshi,et al.  Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study , 2003, Neuroreport.

[59]  G. Helms.  T2-based segmentation of periventricular volumes for quantification of proton magnetic resonance spectra of multiple sclerosis lesions , 2003, Magnetic Resonance Materials in Physics, Biology and Medicine.

[60]  Bruno Alfano,et al.  Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load , 2003, NeuroImage.

[61]  N. Roberts,et al.  C erebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years , 2003, Multiple sclerosis.

[62]  D. Miller,et al.  Interferon β-1a in primary progressive MS , 2003, Neurology.

[63]  J H Simon,et al.  Eight-year follow-up study of brain atrophy in patients with MS , 2002, Neurology.

[64]  P. Matthews,et al.  Thalamic neurodegeneration in multiple sclerosis , 2002, Annals of neurology.

[65]  F. Barkhof,et al.  Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype. , 2002, Archives of neurology.

[66]  P Kapeller,et al.  Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.

[67]  B. Lewis,et al.  Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFN&bgr;-1b , 2002, Neurology.

[68]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[69]  David H. Miller,et al.  Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. , 2002, Brain : a journal of neurology.

[70]  Nick C Fox,et al.  Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[71]  M Rovaris,et al.  Two-year follow-up study of primary and transitional progressive multiple sclerosis , 2002, Multiple sclerosis.

[72]  C. Pozzilli,et al.  MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a , 2002, Multiple sclerosis.

[73]  Erik A Sistermans,et al.  Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. , 2002, Brain : a journal of neurology.

[74]  Craig K. Jones,et al.  Normal‐appearing white matter in multiple sclerosis has heterogeneous, diffusely prolonged T2 , 2002, Magnetic resonance in medicine.

[75]  A J Thompson,et al.  Brain atrophy in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.

[76]  Thomas E. Nichols,et al.  Nonparametric permutation tests for functional neuroimaging: A primer with examples , 2002, Human brain mapping.

[77]  Fred L. Bookstein,et al.  “Voxel-Based Morphometry” Should Not Be Used with Imperfectly Registered Images , 2001, NeuroImage.

[78]  R. Rudick,et al.  Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS , 2001, Neurology.

[79]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[80]  P M Matthews,et al.  Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. , 2001, Brain : a journal of neurology.

[81]  M Rovaris,et al.  Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications. , 2001, Brain : a journal of neurology.

[82]  M. Filippi,et al.  Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS , 2001, Neurology.

[83]  Karl J. Friston,et al.  A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.

[84]  Johan Montagnat,et al.  Automated Estimation of Brain Volume in Multiple Sclerosis with BICCR , 2001, IPMI.

[85]  P M Matthews,et al.  Magnetic resonance imaging of multiple sclerosis: new insights linking pathology to clinical evolution , 2001, Current opinion in neurology.

[86]  B. Trapp,et al.  Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences , 2001, Current opinion in neurology.

[87]  C. Mainero,et al.  Correlates of MS disability assessed in vivo using aggregates of MR quantities , 2001, Neurology.

[88]  Massimo Filippi,et al.  Overview of diffusion-weighted magnetic resonance studies in multiple sclerosis , 2001, Journal of the Neurological Sciences.

[89]  P. Matthews,et al.  Normalized Accurate Measurement of Longitudinal Brain Change , 2001, Journal of computer assisted tomography.

[90]  R. Zivadinov,et al.  MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis , 2001, Neuroradiology.

[91]  R Bakshi,et al.  Regional Brain Atrophy Is Associated With Physical Disability in Multiple Sclerosis: Semiquantitative Magnetic Resonance Imaging and Relationship to Clinical Findings , 2001, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[92]  Nick C Fox,et al.  Haemodialysis and Cerebral Oedema , 2001, Nephron.

[93]  M Rovaris,et al.  Whole brain volume changes in patients with progressive MS treated with cladribine , 2000, Neurology.

[94]  J. Duda,et al.  Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon β-1a , 2000, Multiple sclerosis.

[95]  G J Barker,et al.  The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis. , 2000, Brain : a journal of neurology.

[96]  S J Nelson,et al.  A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosis , 2000, Multiple sclerosis.

[97]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[98]  A. Thompson,et al.  One year follow up study of primary and transitional progressive multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.

[99]  Nick C Fox,et al.  Detection of ventricular enlargement in patients at the earliest clinical stage of MS , 2000, Neurology.

[100]  J. Mugler,et al.  White matter abnormalities in mobility-impaired older persons , 2000, Neurology.

[101]  Nikos Evangelou,et al.  Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis , 2000, Annals of neurology.

[102]  J K Udupa,et al.  Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. , 2000, Radiology.

[103]  M N Rossor,et al.  Progressive cerebral atrophy in MS , 2000, Neurology.

[104]  M Rovaris,et al.  Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.

[105]  R. Rudick,et al.  Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS , 1999, Neurology.

[106]  B. Trapp,et al.  Pathogenesis of tissue injury in MS lesions , 1999, Journal of Neuroimmunology.

[107]  B D Trapp,et al.  Axonal pathology in multiple sclerosis: relationship to neurologic disability. , 1999, Current opinion in neurology.

[108]  A. Dale,et al.  Cortical Surface-Based Analysis II: Inflation, Flattening, and a Surface-Based Coordinate System , 1999, NeuroImage.

[109]  Anders M. Dale,et al.  Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.

[110]  M Rovaris,et al.  Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis , 1998, Neurology.

[111]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[112]  Supun Samarasekera,et al.  Multiple sclerosis lesion quantification using fuzzy-connectedness principles , 1997, IEEE Transactions on Medical Imaging.

[113]  M Quarantelli,et al.  Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach , 1997, Magnetic resonance in medicine.

[114]  A J Thompson,et al.  Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. , 1996, Brain : a journal of neurology.

[115]  L. Amaducci,et al.  Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up. , 1995, Archives of neurology.

[116]  D. Mathalon,et al.  A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. , 1994, Archives of neurology.

[117]  W. Mcdonald.  RACHELLE FISHMAN-MATTHEW MOORE LECTURE: The Pathological and Clinical Dynamics of Multiple Sclerosis , 1994, Journal of neuropathology and experimental neurology.

[118]  D. Miller,et al.  Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon‐β , 1994, Annals of neurology.

[119]  M. Ron,et al.  Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[120]  C. Coffey,et al.  Quantitative cerebral anatomy of the aging human brain , 1992, Neurology.

[121]  M. Reveley,et al.  EFFECTS OF ACUTE DEHYDRATION ON COMPUTERISED TOMOGRAPHIC ASSESSMENT OF CEREBRAL DENSITY AND VENTRICULAR VOLUME , 1982, The Lancet.

[122]  B. Greenwood.  FAILURE TO DETECT ENDOTOXIN IN SERUM OF CHILDREN WITH MALARIA , 1975, The Lancet.

[123]  Richard H. Price,et al.  Black Holes , 1997 .

[124]  Mark Jenkinson,et al.  Voxel-Level Cross-Subject Statistical Analysis of Brain Atrophy in early Relapsing Remitting MS patients , 2003 .

[125]  C R Guttmann,et al.  A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. , 2001, Archives of neurology.

[126]  F. Barkhof,et al.  Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.

[127]  P. Matthews,et al.  Putting Magnetic Resonance Spectroscopy Studies in Context: Axonal Damage and Disability in Multiple Sclerosis , 1998, Seminars in neurology.

[128]  L G Nyúl,et al.  Relapsing-remitting Multiple Sclerosis: Fractional Volumetric Analysis of Gray Matter and White Matter , 2000 .